Perinatal HIV-1 transmission -: Interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort

被引:201
|
作者
Mandelbrot, L
Le Chenadec, J
Berrebi, A
Bongain, M
Bénifla, JL
Delfraissy, JF
Blanche, S
Mayaux, MJ
机构
[1] Hop Cochin Port Royal, Serv Gynecol Obstet 1, F-75014 Paris, France
[2] INSERM, U149, Paris, France
[3] INSERM, U292, Le Kremlin Bicetre, France
[4] Hop La Grave, Serv Gynecol Obstet, Toulouse, France
[5] Hop Archet 2, Serv Gynecol Obstet, Nice, France
[6] Hop Bichat Claude Bernard, Serv Gynecol Obstet, F-75877 Paris, France
[7] Hop Kremlin Bicetre, Serv Med Interne, Le Kremlin Bicetre, France
[8] Hop Necker Enfants Malad, Serv Pediat, Paris, France
来源
关键词
D O I
10.1001/jama.280.1.55
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context.-It is unclear whether elective cesarean delivery may have a protective effect against the transmission of human immunodeficiency virus 1 (HIV-1). Objective.-To investigate whether mode of delivery has an impact on perinatal HIV-1 transmission in the presence of zidovudine prophylaxis. Design.-A prospective cohort study. Setting.-The 85 perinatal centers in the French Perinatal Cohort, from 1985 to 1996. Patients.-A total of 2834 singleton children born to mothers with HIV-1 infection. Main Outcome Measure.-Human immunodeficiency virus 1 infection of the infant. Results.-No zidovudine was used in 1917 pregnancies and zidovudine prophylaxis was used in 902 pregnancies. Cesarean deliveries were performed in 10.9% on an emergent basis and in 8.3% electively, prior to labor or membrane rupture. In 1917 mothers who did not receive zidovudine, of 1877 with information on mode of delivery, 17.2% transmitted HIV-1 to their child. Risk factors statistically significantly associated with transmission were maternal p24 antigenemia, cervicovaginal infections during pregnancy, amniotic fluid color, and rupture of membranes 4 hours or more before delivery. Mode of delivery was not related to transmission. in 902 mothers receiving zidovudine, transmission was 6.4% in 872 with information on mode of delivery, and elective cesarean delivery (n = 133) was associated with a lower transmission rate than emergent cesarean or vaginal delivery (0.8%, 11.4%, and 6.6%, respectively; P=.002). In a multivariate analysis of all mother-child pairs, including obstetrical risk factors, maternal p24 antigenemia, and zidovudine prophylaxis, interaction between mode of delivery and zidovudine prophylaxis was significant (P=.007). In the multivariate analysis of pregnancies with zidovudine prophylaxis, factors related to transmission rate were maternal p24 antigenemia, amniotic fluid color, and mode of delivery. Adjusted odds ratios (95% confidence intervals) were 1.6 (0.7-3.6) for emergent cesarean delivery and 0.2 (0.0-0.9) for elective cesarean delivery (P =.04) in comparison with vaginal delivery. Conclusions.-We observed an interaction between zidovudine prophylaxis and elective cesarean delivery in decreasing transmission of HIV-1 from mother to child. This observation may have clinical implications for prevention.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 50 条
  • [31] REDOX POTENTIAL STATUS IN CHILDREN WITH PERINATAL HIV-1 INFECTION TREATED WITH ZIDOVUDINE
    DEMARTINO, M
    ZAMMARCHI, E
    FILIPPI, L
    DONATI, MA
    MANNELLI, F
    GALLI, L
    VIERUCCI, A
    [J]. AIDS, 1995, 9 (12) : 1381 - 1383
  • [32] Perinatal transmission of HIV in women receiving zidovudine - Abstract and commentary
    Mofenson, LM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (06): : 569 - 570
  • [33] Estimate of the HIV-1 prevalence in pregnant women and effectiveness of zidovudine administered during pregnancy in reducing perinatal transmission
    Amador, JTR
    Contreras, JR
    Bastero, R
    Barrio, C
    Moreno, P
    Delgado, R
    Muñoz, E
    Jiménez, J
    [J]. MEDICINA CLINICA, 2000, 114 (08): : 286 - 291
  • [34] Lack of adequate prenatal care is related to poor implementation of zidovudine prophylaxis to prevent perinatal HIV transmission
    Wilson, TE
    Royce, R
    Lampe, M
    Ickovics, J
    Fernandez, MI
    Koenig, L
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1223 - 1223
  • [35] Heterosexual behavior during pregnancy and perinatal transmission of HIV-1
    Matheson, PB
    Thomas, PA
    Abrams, EJ
    Pliner, V
    Lambert, G
    Bamji, M
    Krasinski, K
    Steketee, R
    Chiasson, MA
    Thea, DM
    Beatrice, ST
    DeBernardo, E
    Hutchison, S
    McVeigh, K
    Oleszko, W
    Punsalang, A
    Alford, T
    Betre, A
    Capelli, M
    Courtland, R
    Cruz, N
    Floyd, J
    FoyeSousou, V
    Jackson, L
    Jessop, DJ
    Lopez, D
    Macias, L
    Ng, D
    Nelson, K
    Rios, J
    Rosenbluth, L
    Savory, R
    Tadros, H
    Weedon, J
    Young, S
    Zhang, ZR
    Daligadu, M
    Hoover, W
    Pollack, H
    Belmore, A
    Carrasquillio, N
    Champion, S
    Floyd, J
    Freedland, C
    Heagarty, M
    Lovich, S
    Nicholas, S
    Prince, P
    Rogers, A
    Suarez, M
    [J]. AIDS, 1996, 10 (11) : 1249 - 1256
  • [36] Short course of AZT halves HIV-1 perinatal transmission
    Morris, K
    [J]. LANCET, 1998, 351 (9103): : 651 - 651
  • [37] MATERNAL RISK-FACTORS FOR PERINATAL TRANSMISSION OF HIV-1
    HUTTO, C
    SCOTT, G
    LAI, S
    MASTRUCCI, T
    PARKS, W
    [J]. PEDIATRIC RESEARCH, 1989, 25 (04) : A163 - A163
  • [38] Perinatal HIV-1 transmission recent advances and therapeutic interventions
    Bryson, YJ
    [J]. AIDS, 1996, 10 : S33 - S42
  • [39] Maternal viral load and the risk of perinatal transmission of HIV-1
    Garcia, PM
    Moye, J
    Lew, JF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (22): : 1699 - 1700
  • [40] Delivery Options for Prevention of Perinatal HIV Transmission
    Fogler, Jess
    Cohan, Deborah
    Weber, Shannon
    Goldschmidt, Ronald
    [J]. AMERICAN FAMILY PHYSICIAN, 2009, 80 (12) : 1356 - 1357